Dario Londoño Trujillo

Dr. Dario Londoño Trujillo

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2022 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Open access
PDF file
ATAlejandra Taborda
Alejandra Taborda
CCCindy Chamorro
Cindy Chamorro
JQJuliana Quintero-Espinosa
Juliana Quintero-Espinosa
GCGabriel Carrasquilla
Gabriel Carrasquilla
DTDario Londoño Trujillo
Dario Londoño Trujillo
Dengue is a public health problem in Colombia and in the municipality of Girardot, an area of high risk for dengue transmission. We present the results of an economic evaluation from the societal perspective and 1-year time horizon comparing the regular control program for dengue prevention versus an intervention that comprised an environmental management strategy by covering the most Aedes aegypti productive breeding sites with insecticide covers, community actions, and educational activities. The effectiveness of the intervention was measured as the reduction in probability of dengue infection obtained from a community trial. Resource use was estimated from clinical records that were validated by clinical experts; unit costs were taken from national tariffs. Patient costs were obtained from a household survey. We found that the intervention generated an additional cost of USD20.9 per household and an incremental effectiveness of 0.00173 (reduction in the probability of reported dengue cases). Overall, both alternatives generate similar effectiveness, but the new intervention was associated with increasing costs. We conclude the new intervention is a potentially cost-effective option in areas where high prevalence of dengue exists.

24 June 2019 in Cost Effectiveness and Resource Allocation
Verified
Journal Article
Open access
PDF file
DTDario Londoño Trujillo
Dario Londoño Trujillo
NSNESTOR SANDOVAL
NESTOR SANDOVAL
ARAlejandra Taborda Restrepo
Alejandra Taborda Restrepo
CVCindy Lorena Chamorro Velasquez
Cindy Lorena Chamorro Velasquez
MTMaria Teresa Dominguez Torres
Maria Teresa Dominguez Torres
RDRodolfo Jose Dennis
Rodolfo Jose Dennis
In many countries, economic assessments of the routine use of pulse oximetry in the detection of Critical Congenital Heart Disease (CCHD) at birth has not yet been carried out. CCHDs necessarily require medical intervention within the first months of life. This assessment is a priority in low and medium resource countries. The purpose of this study was to assess the cost-effectiveness (CE) relation of pulse oximetry in the detection of cases of CCHD in Colombia. A full economic assessment of the cost-effectiveness type was conducted from the perspective of society. A decision tree was constructed to establish a comparison between newborn physical examination plus pulse oximetry, versus physical examination alone, in the diagnosis of CCHDs. The sensitivity and specificity of pulse oximetry were estimated from a systematic review of the literature; to assess resource use, micro-costing analyses and surveys were conducted. The time horizon of the economic evaluation was the first week after birth and until the first year of life. The incremental cost-effectiveness ratio (ICER) was determined and, to control for uncertainty, deterministic and probabilistic sensitivity analysis were made, including the adoption of different scenarios of budgetary impact. All costs are expressed in US dollars from 2017, using the average exchange rate for 2017 [$2,951.15 COP for 1 dollar]. The costs of pulse oximetry screening plus physical examination were $102; $7 higher than physical examination alone. The effectiveness of pulse oximetry plus the physical examination was 0.93; that is, 0.07 more than the physical examination on its own. The ICER was $100 for pulse oximetry screening; that is, if one wishes to increase 1% the probability of a correct CCHD diagnosis, this amount would have to be invested. A willingness to pay of $26.292 USD (direct medical cost) per probability of a correct CCHD diagnosis was assumed. At current rates and from the perspective of society, newborn pulse oximetry screening at 24 h in addition to physical examination, and considering a time horizon of 1 week, is a cost-effective strategy in the early diagnosis of CCHDs in Colombia. Trial registration “retrospectively registered”.

23 January 2019 in F1000Research
Verified
Journal Article
Open access
PDF file
CVCindy Lorena Chamorro Velásquez
Cindy Lorena Chamorro Velásquez
NRNestor Fernando Sandoval Reyes
Nestor Fernando Sandoval Reyes
ARAlejandra Taborda Restrepo
Alejandra Taborda Restrepo
SDSandra Vanessa Romero Ducuara
Sandra Vanessa Romero Ducuara
MDMaria Teresa Domínguez
Maria Teresa Domínguez
DTDario Londoño Trujillo
Dario Londoño Trujillo
Background: Critical congenital heart disease (CCHD) make up a group of heart diseases present in newborns since the prenatal period and requiring early intervention through surgery or percutaneous interventions in the first year of life. Little is known about the societal economic impact associated with their care in low to middle income countries. We estimated direct medical costs, out-of-pocket expenditures and indirect costs of CCHD patients in Colombia. Methods: The methodology to estimate costs involved four stages: identification, measurement, and assessment of resources consumed, and total cost calculation. Regarding medical costs, hospital and ambulatory costs were estimated for the patient’s first year of life using clinical records of 73 patients and with thematic experts. A survey was carried out on 20 children´s caregivers to determine the out-of-pocket expenses and indirect costs. For this estimation, a descriptive analysis was made on the survey taking into account the reported salary. All costs are expressed in US dollars (2017 exchange rates). Results: The average direct medical hospital costs for CCHDs were $25,835 and the ambulatory costs reached $480. Indirect costs were $1,303 and out-of-pocket expenses were $2,058, which for families with an income lower than one monthly minimum wage (1 SMMLV) in 2017 correspond to $250. The impact on their budget was 57%. Conclusions: CCHDs represent an important economic impact both for the Colombian General Social Health System and for families. This study made it possible to estimate the costs that are not easily visible and thus quantified.

2 August 2017 in Revista de la Facultad de Medicina
Verified
Journal Article
Open access
PDF file
DIDavid Ingram
David Ingram
TLTeofilo Lee-Chiong
Teofilo Lee-Chiong
DTDario Londoño Trujillo
Dario Londoño Trujillo
El síndrome de apnea-hipopnea obstructiva del sueño (SAHOS) no tratado se asocia con costos directos e indirectos significativos. Este trastorno también tiene un impacto negativo sobre el desempeño y la seguridad laboral y está implicado en una proporción considerable de accidentes automovilísticos. El diagnóstico oportuno y la terapia óptima han mostrado disminución en la utilización de los sistemas de salud y en los costos, al tiempo que atenúan los riesgos adversos. Del mismo modo, el SAHOS no tratado se asocia con incremento en las tasas de desempleo. Para los profesionales de la salud, tener un paciente con SAHOS involucrado en una colisión automovilística es de crucial importancia debido al daño personal y público, así como la potencial discapacidad física por el accidente. En Latinoamérica se requiere de la medición de los costos directos e indirectos dado el problema de salud pública que tiene asociado el SAHOS y las implicaciones mencionadas.

23 May 2024 in Journal of Health Economics and Outcomes Research
Verified
Journal Article
Open access
PDF file
DTDario Londoño Trujillo
Dario Londoño Trujillo
PGPaula A. Castro García
Paula A. Castro García
KLKristian K. Rojas López
Kristian K. Rojas López
KMKaren J. Moreno-Medina
Karen J. Moreno-Medina
MTMaría T. Dominguez Torres
María T. Dominguez Torres
NRNestor F. Sandoval Reyes
Nestor F. Sandoval Reyes
Background: Congenital heart disease is the most common congenital condition worldwide, with a prevalence of 80 cases per 10 000 live births. In addition to perinatal morbidity and mortality, it entails long-term consequences such as multiple surgeries, prolonged hospitalizations, lifelong cardiac follow-up, reduced quality of life, risk of heart failure, and premature mortality in adulthood. This significant health and economic burden on healthcare systems and families highlights the relevance of evaluating the cost-effectiveness of methods for early detection of this condition. Objective: To conduct a systematic literature review (SLR) to identify and analyze existing economic evaluations on prenatal detection of congenital heart diseases through ultrasound, focusing on the reported cost-effectiveness results and the methodological quality of the evaluated studies according to established criteria. Methods: An SLR of economic evaluations was conducted following PRISMA guidelines. A quantitative synthesis of key methodological components of each economic evaluation was performed. The incremental medical costs, effectiveness measures, and cost-effectiveness ratios reported in each study were compiled and compared. The methodological quality was assessed according to compliance with the 24 CHEERS criteria. Results: We found 785 articles, of which only 7 met all inclusion criteria. Most were cost-effectiveness analyses, with the most common outcome being number of cases detected. Screening with only 4-chamber views interpreted by general practitioners or cardiologists were dominant strategies compared with screening with 4-chamber plus outflow views interpreted by a general practitioner. Fetal echocardiography was most effective but most expensive. Screening with 4-chamber and outflow view, followed by referral to a specialist, were recommended as the least expensive strategy per defect detected. On average, articles met 17 of the 24 CHEERS criteria. Discussion: While recent cost-effectiveness analyses demonstrated improved methodological quality, there was a lack of homogeneity due to differences in comparators and population subgroups analyzed. Despite this heterogeneity, fetal ultrasonography screening was consistently identified as a cost-effective strategy, with its cost-effectiveness heavily influenced by the expertise of the interpreting physician. Conclusion: Most studies recommend implementing obstetric ultrasonography screening, without routine fetal echocardiography, for detecting congenital heart diseases.

23 May 2024 in Journal of Health Economics and Outcomes Research
Verified
Journal Article
Open access
PDF file
DTDario Londoño Trujillo
Dario Londoño Trujillo
PGPaula A. Castro García
Paula A. Castro García
KLKristian K. Rojas López
Kristian K. Rojas López
KMKaren J. Moreno-Medina
Karen J. Moreno-Medina
MTMaría T. Dominguez Torres
María T. Dominguez Torres
NRNestor F. Sandoval Reyes
Nestor F. Sandoval Reyes
Background: Congenital heart disease is the most common congenital condition worldwide, with a prevalence of 80 cases per 10 000 live births. In addition to perinatal morbidity and mortality, it entails long-term consequences such as multiple surgeries, prolonged hospitalizations, lifelong cardiac follow-up, reduced quality of life, risk of heart failure, and premature mortality in adulthood. This significant health and economic burden on healthcare systems and families highlights the relevance of evaluating the cost-effectiveness of methods for early detection of this condition. Objective: To conduct a systematic literature review (SLR) to identify and analyze existing economic evaluations on prenatal detection of congenital heart diseases through ultrasound, focusing on the reported cost-effectiveness results and the methodological quality of the evaluated studies according to established criteria. Methods: An SLR of economic evaluations was conducted following PRISMA guidelines. A quantitative synthesis of key methodological components of each economic evaluation was performed. The incremental medical costs, effectiveness measures, and cost-effectiveness ratios reported in each study were compiled and compared. The methodological quality was assessed according to compliance with the 24 CHEERS criteria. Results: We found 785 articles, of which only 7 met all inclusion criteria. Most were cost-effectiveness analyses, with the most common outcome being number of cases detected. Screening with only 4-chamber views interpreted by general practitioners or cardiologists were dominant strategies compared with screening with 4-chamber plus outflow views interpreted by a general practitioner. Fetal echocardiography was most effective but most expensive. Screening with 4-chamber and outflow view, followed by referral to a specialist, were recommended as the least expensive strategy per defect detected. On average, articles met 17 of the 24 CHEERS criteria. Discussion: While recent cost-effectiveness analyses demonstrated improved methodological quality, there was a lack of homogeneity due to differences in comparators and population subgroups analyzed. Despite this heterogeneity, fetal ultrasonography screening was consistently identified as a cost-effective strategy, with its cost-effectiveness heavily influenced by the expertise of the interpreting physician. Conclusion: Most studies recommend implementing obstetric ultrasonography screening, without routine fetal echocardiography, for detecting congenital heart diseases.